Home » Authors » Karen Young

Karen Young

Articles

ARTICLES

Gilead, Anadys Enter Deal For HTP With Viral Target

June 11, 2002

FeRx Raises $15M To Pay For Phase II/III Trial Of MTC-DOX

June 7, 2002

FeRx Raises $15M To Pay For Phase II/III Trial Of MTC-DOX

June 7, 2002

TransForm, ALZA Sign Deal For Transdermal Products

June 6, 2002

TransForm, ALZA Sign Deal For Transdermal Products

June 6, 2002

ActivX Using Proteomics Platform In Diabetes Alliance With Kyorin

June 5, 2002

Libraria Names New CEO To Help Move Company Forward

June 5, 2002

ActivX Using Proteomics Platform In Diabetes Alliance With Kyorin

June 5, 2002

Libraria Names New CEO To Help Move Company Forward

June 5, 2002

Genta, Aventis Adding Patients To Trial; Move Pushes Back NDA

June 4, 2002

View All Articles by Karen Young

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...